Sinovac, one of the leading COVID-19 vaccine developers, initiated Phase 3 clinical trial in Indonesia where about 800 participants have registered for the clinical trial. Led by Padjajaran University (Unpad), Medical School’s Kusnandi Rusmil reports the clinical...